Neurovascular Intervention Devices Global Market - Forecast to 2027
Over the decade, due to the technological advancements with emerging and innovative technologies used under minimally invasive conditions has led to the rapid development of neurovascular interventions. As a result of rapid advances, there is the great expansion in the potential therapeutic application for neurovascular diseases.
Neurovascular Interventional devices are used to treat intracranial aneurysm, ischemic stroke, arteriovenous malformation, carotid stenosis and other diseases like intracranial stenosis, dural fistula. The Neurovascular Intervention devices global market is expected to grow at a high single digit CAGR from 2020 to 2027. The market is primarily driven by the increase in incidence and prevalence of neurovascular diseases like intracranial aneurysm, stroke and arteriovenous malformations, increase in the aging population, technological advancement, acquisitions and favourable reimbursements and factors such as product recall, complications associated with implanted devices, lack of skilled and trained professionals, emerging alternatives such as stem cell therapies, radiation therapies and also stringent regulatory policies for the product approval due to classification of the neurovascular interventions as class II and III devices thereby hindering the growth of the market.
Neurovascular Intervention devices global market is segmented based on products, applications and geography. The products are segmented into artificial embolization devices, stents, thrombectomy devices and support devices. Among products, the artificial embolization devices segment accounted for the largest share in 2020 and is projected to grow at a low single digit CAGR from 2020 to 2027 due to technological advancements in coils & flow diverter, development of coils for dual application i.e. for intracranial aneurysm and arteriovenous malformation. Further, the artificial embolization devices are sub-segment into coils, liquid embolics, flow diverters, flow disruptors and others (embolic spheres and vascular plugs). The coil segment accounted for the largest share in 2020 due to the development of soft and smart coils.
As Neuroendovascular space has responded to a significant advance in the properties of coils such as pliability, detachment zone, coatings, lengths, and shapes hence, driving the coils market. The flow diverter segment is the fastest-growing segment and is projected to grow at a high single digit CAGR from 2020 to 2027 due to its advantages like the presence of effective embolic materials that penetrates small vessels, nature of self-expansion, cohesiveness and non-adherence when compared to glues. The coils are further classified into bare metal coils and coated coils. The bare metal coil segment accounted for the largest share in 2020 and the coated coil segment is the fastest-growing segment and is projected to grow at a low single digit CAGR from 2020 to 2027 due to increased compatibility, efficacy and cost.
The Stents are sub-segmented into intracranial stents and carotid stents. The carotid stents segment accounted for the largest share in 2020 and is expected to grow at a high single digit CAGR from 2020 to 2027, owing to the development of self-expanding stents and is used in patients who have high surgical risk and also the availability of different stent structures to tailor the procedures in a different subset of lesions in the brain. The intracranial stents are sub-segmented into stenosis stent and aneurysm coil stent. The aneurysm coil stents segment accounted for the largest share in 2020 and the stenosis stent segment is projected to grow at a high single digit CAGR from 2020 to 2027 due to increase in the intracranial aneurysm procedures. The thrombectomy devices are sub-segmented into stent retrievers and aspiration devices. The stent retriever segment accounted the largest share of in 2020 and is expected to grow at a low double digit CAGR from 2020 to 2027 due to product approvals and expansion in indication of treatment from 6 hrs to 24 hrs.
The global neurovascular intervention markets by applications are segmented into intracranial aneurysm, ischemic stroke, arteriovenous malformation and others. Among applications, the intracranial aneurysm segment accounted for the largest share in 2020 due to the increase in incidence and prevalence of intracranial aneurysm and increase in the aging population. The Ischemic stroke segment is fastest-growing segment during the forecasting period with a high single digit CAGR from 2020 to 2027 due to increase in product regulatory approvals of thrombectomy devices, increase in ischemic stroke patients which are in turn driven by the rise in population with smoking, alcohol consumption, hypertension and diabetes, technological advancement in stent retriever and aspiration devices which aids in local arrest of blood flow and removal of thrombus without fragmentation and theses devices can retrieve clots of large size.
The global neurovascular intervention global market by geography is segmented as North America (U.S. and others), Europe (Germany, U.K., France and Others), Asia-Pacific (Japan, China, India, and Others) and Rest of the World (Brazil, Rest of Latin America and Middle East & others). North America accounted for the highest market share followed by Europe in 2020. Favourable reimbursement coverage, adoption of advanced minimally invasive procedures and increase in incidence and prevalence of neurovascular diseases are the driving neurovascular intervention devices market. The Asia-Pacific region is the fastest-growing region with a high single digit CAGR from 2020 to 2027. However, Asian countries especially India and China are the fastest-growing nations at a high single digit CAGR from 2020 to 2027 with its growing awareness of minimally invasive techniques, a gradual increase in the healthcare expenditure and increase in the aging population and reduction in the cost of neurovascular interventions.
The Neurovascular Intervention devices market is a consolidated, highly competitive market and all the existing players in this market are involved in developing new and advanced products to maintain their market shares. Some of the key players of the Neurovascular Intervention devices global market are Stryker Corporation (U.S.), Medtronic Plc (Ireland), Penumbra, Inc. (U.S.), Terumo Corporation (Micro Vention, Japan), Johnson & Johnson (U.S.), Balt Extrusion (France), Abbott Laboratories (U.S.), Boston Scientific Corporation (U.S.), Silk Road Medical Inc. (U.S.), Microport Scientific Corporation (China), and Acandis GmbH (Germany).
The report provides an in-depth market analysis of the above-mentioned segments across the following regions:
Neurovascular Interventional devices are used to treat intracranial aneurysm, ischemic stroke, arteriovenous malformation, carotid stenosis and other diseases like intracranial stenosis, dural fistula. The Neurovascular Intervention devices global market is expected to grow at a high single digit CAGR from 2020 to 2027. The market is primarily driven by the increase in incidence and prevalence of neurovascular diseases like intracranial aneurysm, stroke and arteriovenous malformations, increase in the aging population, technological advancement, acquisitions and favourable reimbursements and factors such as product recall, complications associated with implanted devices, lack of skilled and trained professionals, emerging alternatives such as stem cell therapies, radiation therapies and also stringent regulatory policies for the product approval due to classification of the neurovascular interventions as class II and III devices thereby hindering the growth of the market.
Neurovascular Intervention devices global market is segmented based on products, applications and geography. The products are segmented into artificial embolization devices, stents, thrombectomy devices and support devices. Among products, the artificial embolization devices segment accounted for the largest share in 2020 and is projected to grow at a low single digit CAGR from 2020 to 2027 due to technological advancements in coils & flow diverter, development of coils for dual application i.e. for intracranial aneurysm and arteriovenous malformation. Further, the artificial embolization devices are sub-segment into coils, liquid embolics, flow diverters, flow disruptors and others (embolic spheres and vascular plugs). The coil segment accounted for the largest share in 2020 due to the development of soft and smart coils.
As Neuroendovascular space has responded to a significant advance in the properties of coils such as pliability, detachment zone, coatings, lengths, and shapes hence, driving the coils market. The flow diverter segment is the fastest-growing segment and is projected to grow at a high single digit CAGR from 2020 to 2027 due to its advantages like the presence of effective embolic materials that penetrates small vessels, nature of self-expansion, cohesiveness and non-adherence when compared to glues. The coils are further classified into bare metal coils and coated coils. The bare metal coil segment accounted for the largest share in 2020 and the coated coil segment is the fastest-growing segment and is projected to grow at a low single digit CAGR from 2020 to 2027 due to increased compatibility, efficacy and cost.
The Stents are sub-segmented into intracranial stents and carotid stents. The carotid stents segment accounted for the largest share in 2020 and is expected to grow at a high single digit CAGR from 2020 to 2027, owing to the development of self-expanding stents and is used in patients who have high surgical risk and also the availability of different stent structures to tailor the procedures in a different subset of lesions in the brain. The intracranial stents are sub-segmented into stenosis stent and aneurysm coil stent. The aneurysm coil stents segment accounted for the largest share in 2020 and the stenosis stent segment is projected to grow at a high single digit CAGR from 2020 to 2027 due to increase in the intracranial aneurysm procedures. The thrombectomy devices are sub-segmented into stent retrievers and aspiration devices. The stent retriever segment accounted the largest share of in 2020 and is expected to grow at a low double digit CAGR from 2020 to 2027 due to product approvals and expansion in indication of treatment from 6 hrs to 24 hrs.
The global neurovascular intervention markets by applications are segmented into intracranial aneurysm, ischemic stroke, arteriovenous malformation and others. Among applications, the intracranial aneurysm segment accounted for the largest share in 2020 due to the increase in incidence and prevalence of intracranial aneurysm and increase in the aging population. The Ischemic stroke segment is fastest-growing segment during the forecasting period with a high single digit CAGR from 2020 to 2027 due to increase in product regulatory approvals of thrombectomy devices, increase in ischemic stroke patients which are in turn driven by the rise in population with smoking, alcohol consumption, hypertension and diabetes, technological advancement in stent retriever and aspiration devices which aids in local arrest of blood flow and removal of thrombus without fragmentation and theses devices can retrieve clots of large size.
The global neurovascular intervention global market by geography is segmented as North America (U.S. and others), Europe (Germany, U.K., France and Others), Asia-Pacific (Japan, China, India, and Others) and Rest of the World (Brazil, Rest of Latin America and Middle East & others). North America accounted for the highest market share followed by Europe in 2020. Favourable reimbursement coverage, adoption of advanced minimally invasive procedures and increase in incidence and prevalence of neurovascular diseases are the driving neurovascular intervention devices market. The Asia-Pacific region is the fastest-growing region with a high single digit CAGR from 2020 to 2027. However, Asian countries especially India and China are the fastest-growing nations at a high single digit CAGR from 2020 to 2027 with its growing awareness of minimally invasive techniques, a gradual increase in the healthcare expenditure and increase in the aging population and reduction in the cost of neurovascular interventions.
The Neurovascular Intervention devices market is a consolidated, highly competitive market and all the existing players in this market are involved in developing new and advanced products to maintain their market shares. Some of the key players of the Neurovascular Intervention devices global market are Stryker Corporation (U.S.), Medtronic Plc (Ireland), Penumbra, Inc. (U.S.), Terumo Corporation (Micro Vention, Japan), Johnson & Johnson (U.S.), Balt Extrusion (France), Abbott Laboratories (U.S.), Boston Scientific Corporation (U.S.), Silk Road Medical Inc. (U.S.), Microport Scientific Corporation (China), and Acandis GmbH (Germany).
The report provides an in-depth market analysis of the above-mentioned segments across the following regions:
- North America
- U.S.
- Others
- Europe
- Germany
- U.K.
- France
- Others
- Asia-Pacific
- Japan
- China
- India
- Others
- Rest of the World (RoW)
- Brazil
- Rest of Latin America
- Middle East & Others
1 EXECUTIVE SUMMARY
2 INTRODUCTION
2.1 KEY TAKEAWAYS
2.2 REPORT SCOPE
2.3 REPORT DESCRIPTION
2.4 MARKETS COVERED
2.5 STAKEHOLDERS
2.6 RESEARCH METHODOLOGY
2.6.1 MARKET SIZE ESTIMATION
2.6.2 MARKET BREAKDOWN AND DATA TRIANGULATION
2.6.3 SECONDARY SOURCE
2.6.4 PRIMARY SOURCES
2.6.5 KEY DATA POINTS FROM SECONDARY SOURCES
2.6.6 KEY DATA POINTS FROM PRIMARY SOURCES
2.6.7 ASSUMPTIONS
3 MARKET ANALYSIS
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 FACTORS INFLUENCING MARKET
3.3.1 DRIVERS AND OPPORTUNITIES
3.3.1.1 Increase in incidence and prevalence of neurovascular diseases
3.3.1.2 Technological advancements in minimally invasive products
3.3.1.3 Favorable reimbursement policies
3.3.1.4 Increase in the ageing population
3.3.1.5 Acquisitions and partnerships as a part of the growth strategy
3.3.2 RESTRAINTS AND THREATS
3.3.2.1 Adverse events and complications with the implantations of neurovascular intervention devices
3.3.2.2 Lack of skilled and trained professionals
3.3.2.3 Product recalls
3.3.2.4 Stringent regulatory policies
3.3.2.5 Availability of alternative products
3.4 REGULATORY AFFAIRS
3.4.1 INTERNATIONAL ORGANIZATION FOR STANDARDIZATION
3.4.1.1 ISO 9001: 2015 quality management system
3.4.1.2 ISO 13485 medical devices
3.4.1.3 ISO 10993 biological evaluation of medical devices
3.4.2 THE U.S.
3.4.3 CANADA
3.4.4 EUROPE
3.4.5 JAPAN
3.4.6 CHINA
3.4.7 INDIA
3.5 REIMBURSEMENT SCENARIO
3.5.1 REIMBURSEMENT TABLE
3.6 FUNDING SCENARIO
3.7 PATENT TRENDS
3.8 TECHNOLOGICAL ADVANCEMENTS
3.8.1 INTRODUCTION
3.8.2 ADVANCEMENT IN THROMBECTOMY DEVICES
3.8.3 EMBOLIZATION
3.8.4 LIQUID EMBOLIZATION
3.8.5 FLOW DIVERTER
3.8.6 OTHER DEVICES
3.9 PRODUCT APPROVALS
3.10 PORTER’S FIVE FORCE ANALYSIS
3.10.1 THREAT OF NEW ENTRANTS
3.10.2 THREAT OF SUBSTITUTES
3.10.3 RIVALRY AMONG EXISTING COMPETITORS
3.10.4 BARGAINING POWER OF SUPPLIERS
3.10.5 BARGAINING POWER OF BUYERS
3.11 SUPPLY CHAIN ANALYSIS
3.12 MARKET SHARE ANALYSIS BY MAJOR PLAYERS
3.12.1 NEUROVASCULAR INTERVENTIONAL DEVICES GLOBAL MARKET SHARE ANALYSIS
3.12.2 COILS GLOBAL MARKET SHARE ANALYSIS
3.12.3 FLOW DIVERTERS GLOBAL MARKET SHARE ANALYSIS
3.12.4 INTRACRANIAL STENT GLOBAL MARKET SHARE ANALYSIS
3.12.5 CAROTID STENT GLOBAL MARKET SHARE ANALYSIS
3.12.6 STENT RETRIEVER GLOBAL MARKET SHARE ANALYSIS
3.12.7 ASPIRATION CATHETERS GLOBAL MARKET SHARE ANALYSIS
3.12.8 LIQUID EMBOLICS GLOBAL MARKET SHARE ANALYSIS
3.13 NEUROVASCULAR INTERVENTION DEVICES NUMBER OF UNITS BY REGION
3.13.1 COILS NUMBER OF UNITS BY REGION
3.13.2 LIQUID EMBOLICS NUMBER OF UNITS BY REGION
3.13.3 STENT RETRIEVER NUMBER OF UNITS BY REGION
3.13.4 ASPIRATION DEVICES NUMBER OF UNITS BY REGION
3.13.5 INTRACRANIAL STENTS NUMBER OF UNITS BY REGION
3.13.6 CAROTID STENT NUMBER OF UNITS BY REGION
3.14 NEUROVASCULAR INTERVENTION DEVICES COMPANY COMPARISON TABLE BY CLASSIFICATION, PRODUCTS AND APPLICATIONS
3.15 MARKET PENETRATION OF NEUROVASCULAR INTERVENTION DEVICES MARKET
4 NEUROVASCULAR INTERVENTION DEVICES GLOBAL MARKET, BY PRODUCT
4.1 INTRODUCTION
4.2 ARTIFICIAL EMBOLIZATION DEVICES
4.2.1 COILS
4.2.1.1 Bare metal coils
4.2.1.2 Coated coils
4.2.2 LIQUID EMBOLICS
4.2.3 FLOW DIVERTERS
4.2.4 FLOW DISRUPTOR
4.2.5 OTHERS
4.3 STENTS
4.3.1 INTRACRANIAL STENTS
4.3.1.1 Stenosis stents
4.3.1.2 Aneurysm coil stents
4.3.2 CAROTID STENTS
4.4 THROMBECTOMY DEVICES
4.4.1 STENT RETRIEVERS
4.4.2 ASPIRATION DEVICES
4.5 SUPPORT DEVICES
5 NEUROVASCULAR INTERVENTION DEVICES GLOBAL MARKET, BY APPLICATION
5.1 INTRODUCTION
5.2 INTRACRANIAL ANEURYSM
5.3 ISCHEMIC STROKE
5.4 ARTERIOVENOUS MALFORMATION
5.5 OTHER DISEASES
6 REGIONAL ANALYSIS
6.1 INTRODUCTION
6.2 NORTH AMERICA
6.2.1 U.S.
6.2.2 REST OF NORTH AMERICA
6.3 EUROPE
6.3.1 GERMANY
6.3.2 U.K.
6.3.3 FRANCE
6.3.4 REST OF EUROPE
6.4 APAC
6.4.1 JAPAN
6.4.2 CHINA
6.4.3 INDIA
6.4.4 REST OF APAC
6.5 REST OF THE WORLD
6.5.1 BRAZIL
6.5.2 REST OF LATIN AMERICA
6.5.3 MIDDLE EAST AND OTHERS
7 COMPETITIVE LANDSCAPE
7.1 INTRODUCTION
7.2 PRODUCT APPROVAL
7.3 AGREEMENTS
7.4 PRODUCT LAUNCH
7.5 ACQUISITION
7.6 OTHER DEVELOPMENTS
8 MAJOR COMPANIES
8.1 ABBOTT LABORATORIES
8.1.1 OVERVIEW
8.1.2 FINANCIALS
8.1.3 PRODUCT PORTFOLIO
8.1.4 KEY DEVELOPMENTS
8.1.5 BUSINESS STRATEGY
8.1.6 SWOT ANALYSIS
8.2 BALT EXTRUSION
8.2.1 OVERVIEW
8.2.2 FINANCIALS
8.2.3 PRODUCT PORTFOLIO
8.2.4 KEY DEVELOPMENTS
8.2.5 BUSINESS STRATEGY
8.2.6 SWOT ANALYSIS
8.3 BOSTON SCIENTIFIC CORPORATION
8.3.1 OVERVIEW
8.3.2 FINANCIALS
8.3.3 PRODUCT PORTFOLIO
8.3.4 KEY DEVELOPMENTS
8.3.5 BUSINESS STRATEGY
8.3.6 SWOT ANALYSIS
8.4 JOHNSON & JOHNSON (CERENOVUS)
8.4.1 OVERVIEW
8.4.2 FINANCIALS
8.4.3 PRODUCT PORTFOLIO
8.4.4 KEY DEVELOPMENTS
8.4.5 BUSINESS STRATEGY
8.4.6 SWOT ANALYSIS
8.5 MEDTRONIC PUBLIC LIMITED COMPANY
8.5.1 OVERVIEW
8.5.2 FINANCIALS
8.5.3 PRODUCT PORTFOLIO
8.5.4 KEY DEVELOPMENTS
8.5.5 BUSINESS STRATEGY
8.5.6 SWOT ANALYSIS
8.6 MICROPORT SCIENTIFIC CORPORATION
8.6.1 OVERVIEW
8.6.2 FINANCIALS
8.6.3 PRODUCT PORTFOLIO
8.6.4 KEY DEVELOPMENTS
8.6.5 BUSINESS STRATEGY
8.6.6 SWOT ANALYSIS
8.7 PENUMBRA, INC
8.7.1 OVERVIEW
8.7.2 FINANCIALS
8.7.3 PRODUCT PORTFOLIO
8.7.4 KEY DEVELOPMENTS
8.7.5 BUSINESS STRATEGY
8.7.6 SWOT ANALYSIS
8.8 SILK ROAD MEDICAL, INC
8.8.1 OVERVIEW
8.8.2 FINANCIALS
8.8.3 PRODUCT PORTFOLIO
8.8.4 KEY DEVELOPMENTS
8.8.5 BUSINESS STRATEGY
8.8.6 SWOT ANALYSIS
8.9 STRYKER CORPORATION
8.9.1 OVERVIEW
8.9.2 FINANCIALS
8.9.3 PRODUCT PORTFOLIO
8.9.4 KEY DEVELOPMENTS
8.9.5 BUSINESS STRATEGY
8.9.6 SWOT ANALYSIS
8.10 TERUMO CORPORATION
8.10.1 OVERVIEW
8.10.2 FINANCIALS
8.10.3 PRODUCT PORTFOLIO
8.10.4 KEY DEVELOPMENTS
8.10.5 BUSINESS STRATEGY
8.10.6 SWOT ANALYSIS
2 INTRODUCTION
2.1 KEY TAKEAWAYS
2.2 REPORT SCOPE
2.3 REPORT DESCRIPTION
2.4 MARKETS COVERED
2.5 STAKEHOLDERS
2.6 RESEARCH METHODOLOGY
2.6.1 MARKET SIZE ESTIMATION
2.6.2 MARKET BREAKDOWN AND DATA TRIANGULATION
2.6.3 SECONDARY SOURCE
2.6.4 PRIMARY SOURCES
2.6.5 KEY DATA POINTS FROM SECONDARY SOURCES
2.6.6 KEY DATA POINTS FROM PRIMARY SOURCES
2.6.7 ASSUMPTIONS
3 MARKET ANALYSIS
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 FACTORS INFLUENCING MARKET
3.3.1 DRIVERS AND OPPORTUNITIES
3.3.1.1 Increase in incidence and prevalence of neurovascular diseases
3.3.1.2 Technological advancements in minimally invasive products
3.3.1.3 Favorable reimbursement policies
3.3.1.4 Increase in the ageing population
3.3.1.5 Acquisitions and partnerships as a part of the growth strategy
3.3.2 RESTRAINTS AND THREATS
3.3.2.1 Adverse events and complications with the implantations of neurovascular intervention devices
3.3.2.2 Lack of skilled and trained professionals
3.3.2.3 Product recalls
3.3.2.4 Stringent regulatory policies
3.3.2.5 Availability of alternative products
3.4 REGULATORY AFFAIRS
3.4.1 INTERNATIONAL ORGANIZATION FOR STANDARDIZATION
3.4.1.1 ISO 9001: 2015 quality management system
3.4.1.2 ISO 13485 medical devices
3.4.1.3 ISO 10993 biological evaluation of medical devices
3.4.2 THE U.S.
3.4.3 CANADA
3.4.4 EUROPE
3.4.5 JAPAN
3.4.6 CHINA
3.4.7 INDIA
3.5 REIMBURSEMENT SCENARIO
3.5.1 REIMBURSEMENT TABLE
3.6 FUNDING SCENARIO
3.7 PATENT TRENDS
3.8 TECHNOLOGICAL ADVANCEMENTS
3.8.1 INTRODUCTION
3.8.2 ADVANCEMENT IN THROMBECTOMY DEVICES
3.8.3 EMBOLIZATION
3.8.4 LIQUID EMBOLIZATION
3.8.5 FLOW DIVERTER
3.8.6 OTHER DEVICES
3.9 PRODUCT APPROVALS
3.10 PORTER’S FIVE FORCE ANALYSIS
3.10.1 THREAT OF NEW ENTRANTS
3.10.2 THREAT OF SUBSTITUTES
3.10.3 RIVALRY AMONG EXISTING COMPETITORS
3.10.4 BARGAINING POWER OF SUPPLIERS
3.10.5 BARGAINING POWER OF BUYERS
3.11 SUPPLY CHAIN ANALYSIS
3.12 MARKET SHARE ANALYSIS BY MAJOR PLAYERS
3.12.1 NEUROVASCULAR INTERVENTIONAL DEVICES GLOBAL MARKET SHARE ANALYSIS
3.12.2 COILS GLOBAL MARKET SHARE ANALYSIS
3.12.3 FLOW DIVERTERS GLOBAL MARKET SHARE ANALYSIS
3.12.4 INTRACRANIAL STENT GLOBAL MARKET SHARE ANALYSIS
3.12.5 CAROTID STENT GLOBAL MARKET SHARE ANALYSIS
3.12.6 STENT RETRIEVER GLOBAL MARKET SHARE ANALYSIS
3.12.7 ASPIRATION CATHETERS GLOBAL MARKET SHARE ANALYSIS
3.12.8 LIQUID EMBOLICS GLOBAL MARKET SHARE ANALYSIS
3.13 NEUROVASCULAR INTERVENTION DEVICES NUMBER OF UNITS BY REGION
3.13.1 COILS NUMBER OF UNITS BY REGION
3.13.2 LIQUID EMBOLICS NUMBER OF UNITS BY REGION
3.13.3 STENT RETRIEVER NUMBER OF UNITS BY REGION
3.13.4 ASPIRATION DEVICES NUMBER OF UNITS BY REGION
3.13.5 INTRACRANIAL STENTS NUMBER OF UNITS BY REGION
3.13.6 CAROTID STENT NUMBER OF UNITS BY REGION
3.14 NEUROVASCULAR INTERVENTION DEVICES COMPANY COMPARISON TABLE BY CLASSIFICATION, PRODUCTS AND APPLICATIONS
3.15 MARKET PENETRATION OF NEUROVASCULAR INTERVENTION DEVICES MARKET
4 NEUROVASCULAR INTERVENTION DEVICES GLOBAL MARKET, BY PRODUCT
4.1 INTRODUCTION
4.2 ARTIFICIAL EMBOLIZATION DEVICES
4.2.1 COILS
4.2.1.1 Bare metal coils
4.2.1.2 Coated coils
4.2.2 LIQUID EMBOLICS
4.2.3 FLOW DIVERTERS
4.2.4 FLOW DISRUPTOR
4.2.5 OTHERS
4.3 STENTS
4.3.1 INTRACRANIAL STENTS
4.3.1.1 Stenosis stents
4.3.1.2 Aneurysm coil stents
4.3.2 CAROTID STENTS
4.4 THROMBECTOMY DEVICES
4.4.1 STENT RETRIEVERS
4.4.2 ASPIRATION DEVICES
4.5 SUPPORT DEVICES
5 NEUROVASCULAR INTERVENTION DEVICES GLOBAL MARKET, BY APPLICATION
5.1 INTRODUCTION
5.2 INTRACRANIAL ANEURYSM
5.3 ISCHEMIC STROKE
5.4 ARTERIOVENOUS MALFORMATION
5.5 OTHER DISEASES
6 REGIONAL ANALYSIS
6.1 INTRODUCTION
6.2 NORTH AMERICA
6.2.1 U.S.
6.2.2 REST OF NORTH AMERICA
6.3 EUROPE
6.3.1 GERMANY
6.3.2 U.K.
6.3.3 FRANCE
6.3.4 REST OF EUROPE
6.4 APAC
6.4.1 JAPAN
6.4.2 CHINA
6.4.3 INDIA
6.4.4 REST OF APAC
6.5 REST OF THE WORLD
6.5.1 BRAZIL
6.5.2 REST OF LATIN AMERICA
6.5.3 MIDDLE EAST AND OTHERS
7 COMPETITIVE LANDSCAPE
7.1 INTRODUCTION
7.2 PRODUCT APPROVAL
7.3 AGREEMENTS
7.4 PRODUCT LAUNCH
7.5 ACQUISITION
7.6 OTHER DEVELOPMENTS
8 MAJOR COMPANIES
8.1 ABBOTT LABORATORIES
8.1.1 OVERVIEW
8.1.2 FINANCIALS
8.1.3 PRODUCT PORTFOLIO
8.1.4 KEY DEVELOPMENTS
8.1.5 BUSINESS STRATEGY
8.1.6 SWOT ANALYSIS
8.2 BALT EXTRUSION
8.2.1 OVERVIEW
8.2.2 FINANCIALS
8.2.3 PRODUCT PORTFOLIO
8.2.4 KEY DEVELOPMENTS
8.2.5 BUSINESS STRATEGY
8.2.6 SWOT ANALYSIS
8.3 BOSTON SCIENTIFIC CORPORATION
8.3.1 OVERVIEW
8.3.2 FINANCIALS
8.3.3 PRODUCT PORTFOLIO
8.3.4 KEY DEVELOPMENTS
8.3.5 BUSINESS STRATEGY
8.3.6 SWOT ANALYSIS
8.4 JOHNSON & JOHNSON (CERENOVUS)
8.4.1 OVERVIEW
8.4.2 FINANCIALS
8.4.3 PRODUCT PORTFOLIO
8.4.4 KEY DEVELOPMENTS
8.4.5 BUSINESS STRATEGY
8.4.6 SWOT ANALYSIS
8.5 MEDTRONIC PUBLIC LIMITED COMPANY
8.5.1 OVERVIEW
8.5.2 FINANCIALS
8.5.3 PRODUCT PORTFOLIO
8.5.4 KEY DEVELOPMENTS
8.5.5 BUSINESS STRATEGY
8.5.6 SWOT ANALYSIS
8.6 MICROPORT SCIENTIFIC CORPORATION
8.6.1 OVERVIEW
8.6.2 FINANCIALS
8.6.3 PRODUCT PORTFOLIO
8.6.4 KEY DEVELOPMENTS
8.6.5 BUSINESS STRATEGY
8.6.6 SWOT ANALYSIS
8.7 PENUMBRA, INC
8.7.1 OVERVIEW
8.7.2 FINANCIALS
8.7.3 PRODUCT PORTFOLIO
8.7.4 KEY DEVELOPMENTS
8.7.5 BUSINESS STRATEGY
8.7.6 SWOT ANALYSIS
8.8 SILK ROAD MEDICAL, INC
8.8.1 OVERVIEW
8.8.2 FINANCIALS
8.8.3 PRODUCT PORTFOLIO
8.8.4 KEY DEVELOPMENTS
8.8.5 BUSINESS STRATEGY
8.8.6 SWOT ANALYSIS
8.9 STRYKER CORPORATION
8.9.1 OVERVIEW
8.9.2 FINANCIALS
8.9.3 PRODUCT PORTFOLIO
8.9.4 KEY DEVELOPMENTS
8.9.5 BUSINESS STRATEGY
8.9.6 SWOT ANALYSIS
8.10 TERUMO CORPORATION
8.10.1 OVERVIEW
8.10.2 FINANCIALS
8.10.3 PRODUCT PORTFOLIO
8.10.4 KEY DEVELOPMENTS
8.10.5 BUSINESS STRATEGY
8.10.6 SWOT ANALYSIS
LIST OF TABLES
TABLE 1 NEUROVASCULAR INTERVENTION DEVICES GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
TABLE 2 COILS NUMBER OF UNITS, BY REGION, (2019-2027) (NO’S)
TABLE 3 LIQUID EMBOLICS NUMBER OF UNITS, BY REGION, (2019-2027) (NO’S)
TABLE 4 STENT RETRIEVER NUMBER OF UNITS, BY REGION, (2019-2027) (NO’S)
TABLE 5 ASPIRATION DEVICES NUMBER OF UNITS, BY REGION, (2019-2027) (NO’S)
TABLE 6 INTRACRANIAL STENTS NUMBER OF UNITS, BY REGION, (2019-2027) (NO’S)
TABLE 7 CAROTID STENT NUMBER OF UNITS, BY REGION, (2019-2027) (NO’S)
TABLE 8 NEUROVASCULAR INTERVENTION DEVICES GLOBAL MARKET REVENUE, BY PRODUCT, (2019-2027) ($MN)
TABLE 9 ARTIFICIAL EMBOLIZATION DEVICES GLOBAL MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
TABLE 10 ARTIFICIAL EMBOLIZATION DEVICES GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
TABLE 11 COILS GLOBAL MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
TABLE 12 COILS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
TABLE 13 BARE METAL COILS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
TABLE 14 COATED COILS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
TABLE 15 LIQUID EMBOLICS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
TABLE 16 FLOW DIVERTERS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
TABLE 17 FLOW DISRUPTOR GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
TABLE 18 OTHERS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
TABLE 19 STENTS GLOBAL MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
TABLE 20 STENTS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
TABLE 21 INTRACRANIAL STENTS GLOBAL MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
TABLE 22 INTRACRANIAL STENTS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
TABLE 23 STENOSIS STENTS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
TABLE 24 ANEURYSM COIL STENTS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
TABLE 25 CAROTID STENTS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
TABLE 26 THROMBECTOMY DEVICES GLOBAL MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
TABLE 27 THROMBECTOMY DEVICES GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
TABLE 28 STENT RETRIEVERS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
TABLE 29 ASPIRATION DEVICES GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
TABLE 30 SUPPORT DEVICES GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
TABLE 31 NEUROVASCULAR INTERVENTION DEVICES GLOBAL MARKET REVENUE, BY APPLICATION, (2019-2027) ($MN)
TABLE 32 INTRACRANIAL ANEURYSM GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
TABLE 33 ISCHEMIC STROKE GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
TABLE 34 ARTERIOVENOUS MALFORMATION GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
TABLE 35 OTHER DISEASES GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
TABLE 36 NEUROVASCULAR INTERVENTION DEVICES GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
TABLE 37 NORTH AMERICA NEUROVASCULAR INTERVENTION DEVICES MARKET REVENUE, BY PRODUCT, (2019-2027) ($MN)
TABLE 38 NORTH AMERICA ARTIFICIAL EMBOLIZATION DEVICES MARKET, BY PRODUCT TYPE, (2019-2027) ($MN)
TABLE 39 NORTH AMERICA COILS MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
TABLE 40 NORTH AMERICA STENTS MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
TABLE 41 NORTH AMERICA INTRACRANIAL STENTS MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
TABLE 42 NORTH AMERICA THROMBECTOMY DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
TABLE 43 NORTH AMERICA NEUROVASCULAR INTERVENTION DEVICES MARKET REVENUE, BY APPLICATION, (2019-2027) ($MN)
TABLE 44 NORTH AMERICA NEUROVASCULAR INTERVENTION DEVICES MARKET REVENUE, BY COUNTRY, (2019-2027) ($MN)
TABLE 45 EUROPE NEUROVASCULAR INTERVENTION DEVICES MARKET REVENUE, BY PRODUCT, (2019-2027) ($MN)
TABLE 46 EUROPE ARTIFICIAL EMBOLIZATION DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
TABLE 47 EUROPE COILS MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
TABLE 48 EUROPE STENTS MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
TABLE 49 EUROPE INTRACRANIAL STENTS MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
TABLE 50 EUROPE THROMBECTOMY DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
TABLE 51 EUROPE NEUROVASCULAR INTERVENTION DEVICES MARKET REVENUE, BY APPLICATION, (2019-2027) ($MN)
TABLE 52 EUROPE NEUROVASCULAR INTERVENTION DEVICES MARKET REVENUE, BY COUNTRY, (2019-2027) ($MN)
TABLE 53 APAC NEUROVASCULAR INTERVENTION DEVICES MARKET REVENUE, BY PRODUCT, (2019-2027) ($MN)
TABLE 54 APAC ARTIFICIAL EMBOLIZATION DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
TABLE 55 APAC COILS MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
TABLE 56 APAC STENTS MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
TABLE 57 APAC INTRACRANIAL STENTS MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
TABLE 58 APAC THROMBECTOMY DEVICE MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
TABLE 59 APAC NEUROVASCULAR INTERVENTION DEVICES MARKET REVENUE, BY APPLICATION, (2019-2027) ($MN)
TABLE 60 APAC NEUROVASCULAR INTERVENTION DEVICES MARKET REVENUE, BY COUNTRY, (2019-2027) ($MN)
TABLE 61 ROW NEUROVASCULAR INTERVENTION DEVICES MARKET REVENUE, BY PRODUCT, (2019-2027) ($MN)
TABLE 62 ROW ARTIFICIAL EMBOLIZATION DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
TABLE 63 ROW COILS MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
TABLE 64 ROW STENTS MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
TABLE 65 ROW INTRACRANIAL STENTS MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
TABLE 66 ROW THROMBECTOMY DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
TABLE 67 ROW NEUROVASCULAR INTERVENTION DEVICES MARKET REVENUE, BY APPLICATION, (2019-2027) ($MN)
TABLE 68 ROW NEUROVASCULAR INTERVENTION DEVICES MARKET REVENUE, BY COUNTRY, (2019-2027) ($MN)
TABLE 69 KEY DEVELOPMENTS (2018 –2020)
TABLE 70 PRODUCT APPROVAL
TABLE 71 AGREEMENTS
TABLE 72 PRODUCT LAUNCH
TABLE 73 ACQUISITION
TABLE 74 OTHER DEVELOPMENTS
TABLE 75 ABBOTT LABORATORIES: TOTAL REVENUE AND R&D EXPENSES, (2018-2020) ($MN)
TABLE 76 ABBOTT LABORATORIES: TOTAL REVENUE BY SEGMENTS, (2018-2020) ($MN)
TABLE 77 ABBOTT LABORATORIES: MEDICAL DEVICES REVENUE BY SUB-SEGMENTS, (2018-2020) ($MN)
TABLE 78 ABBOTT LABORATORIES: TOTAL REVENUE BY GEOGRAPHY, (2018-2020) ($MN)
TABLE 79 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2018-2020) ($MN)
TABLE 80 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2018-2020) ($MN)
TABLE 81 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2018-2020) ($MN)
TABLE 82 JOHNSON & JOHNSON: TOTAL REVENUE AND R&D EXPENSES, (2018 -2020) ($MN)
TABLE 83 JOHNSON & JOHNSON: TOTAL REVENUE, BY SEGMENTS, (2018-2020) ($MN)
TABLE 84 JOHNSON & JOHNSON: MEDICAL DEVICE REVENUE, BY SUB-SEGMENTS, (2018-2020) ($MN)
TABLE 85 JOHNSON & JOHNSON: TOTAL REVENUE, BY GEOGRAPHY, (2018-2020) ($MN)
TABLE 86 MEDTRONIC PLC: TOTAL REVENUE AND OPERATING EXPENSES (2019-2021) ($MN)
TABLE 87 MEDTRONIC PLC: TOTAL REVENUE, BY SEGMENT, (2019-2021) ($MN)
TABLE 88 MEDTRONIC PLC: TOTAL REVENUE, BY GEOGRAPHY, (2019-2021) ($MN)
TABLE 89 MICROPORT SCIENTIFIC CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2018-2020) ($MN)
TABLE 90 MICROPORT SCIENTIFIC CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2018-2020) ($MN)
TABLE 91 MICROPORT SCIENTIFIC CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2017-2019) ($MN)
TABLE 92 PENUMBRA, INC: TOTAL REVENUE AND R&D EXPENSES, (2018-2020) ($MN)
TABLE 93 PENUMBRA, INC: TOTAL REVENUE, BY SEGMENTS, (2018-2020) ($MN)
TABLE 94 PENUMBRA, INC: TOTAL REVENUE, BY GEOGRAPHY, (2018-2020) ($MN)
TABLE 95 SILK ROAD MEDICAL INC: TOTAL REVENUE AND OPERATING EXPENSES (2018 -2020) ($MN)
TABLE 96 STRYKER CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2018-2020) ($MN)
TABLE 97 STRYKER CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2018-2020) ($MN)
TABLE 98 STRYKER CORPORATION: NEUROTECHNOLOGY AND SPINE REVENUE, BY SUB-SEGMENT, (2018-2020) ($MN)
TABLE 99 STRYKER CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2018-2020) ($MN)
TABLE 100 TERUMO CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2017-2019) ($MN)
TABLE 101 TERUMO CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2017-2019) ($MN)
TABLE 102 TERUMO CORPORATION: TOTAL REVENUE, BY GEOGRAPHY (2017-2019) ($MN)
TABLE 1 NEUROVASCULAR INTERVENTION DEVICES GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
TABLE 2 COILS NUMBER OF UNITS, BY REGION, (2019-2027) (NO’S)
TABLE 3 LIQUID EMBOLICS NUMBER OF UNITS, BY REGION, (2019-2027) (NO’S)
TABLE 4 STENT RETRIEVER NUMBER OF UNITS, BY REGION, (2019-2027) (NO’S)
TABLE 5 ASPIRATION DEVICES NUMBER OF UNITS, BY REGION, (2019-2027) (NO’S)
TABLE 6 INTRACRANIAL STENTS NUMBER OF UNITS, BY REGION, (2019-2027) (NO’S)
TABLE 7 CAROTID STENT NUMBER OF UNITS, BY REGION, (2019-2027) (NO’S)
TABLE 8 NEUROVASCULAR INTERVENTION DEVICES GLOBAL MARKET REVENUE, BY PRODUCT, (2019-2027) ($MN)
TABLE 9 ARTIFICIAL EMBOLIZATION DEVICES GLOBAL MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
TABLE 10 ARTIFICIAL EMBOLIZATION DEVICES GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
TABLE 11 COILS GLOBAL MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
TABLE 12 COILS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
TABLE 13 BARE METAL COILS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
TABLE 14 COATED COILS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
TABLE 15 LIQUID EMBOLICS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
TABLE 16 FLOW DIVERTERS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
TABLE 17 FLOW DISRUPTOR GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
TABLE 18 OTHERS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
TABLE 19 STENTS GLOBAL MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
TABLE 20 STENTS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
TABLE 21 INTRACRANIAL STENTS GLOBAL MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
TABLE 22 INTRACRANIAL STENTS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
TABLE 23 STENOSIS STENTS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
TABLE 24 ANEURYSM COIL STENTS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
TABLE 25 CAROTID STENTS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
TABLE 26 THROMBECTOMY DEVICES GLOBAL MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
TABLE 27 THROMBECTOMY DEVICES GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
TABLE 28 STENT RETRIEVERS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
TABLE 29 ASPIRATION DEVICES GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
TABLE 30 SUPPORT DEVICES GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
TABLE 31 NEUROVASCULAR INTERVENTION DEVICES GLOBAL MARKET REVENUE, BY APPLICATION, (2019-2027) ($MN)
TABLE 32 INTRACRANIAL ANEURYSM GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
TABLE 33 ISCHEMIC STROKE GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
TABLE 34 ARTERIOVENOUS MALFORMATION GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
TABLE 35 OTHER DISEASES GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
TABLE 36 NEUROVASCULAR INTERVENTION DEVICES GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
TABLE 37 NORTH AMERICA NEUROVASCULAR INTERVENTION DEVICES MARKET REVENUE, BY PRODUCT, (2019-2027) ($MN)
TABLE 38 NORTH AMERICA ARTIFICIAL EMBOLIZATION DEVICES MARKET, BY PRODUCT TYPE, (2019-2027) ($MN)
TABLE 39 NORTH AMERICA COILS MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
TABLE 40 NORTH AMERICA STENTS MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
TABLE 41 NORTH AMERICA INTRACRANIAL STENTS MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
TABLE 42 NORTH AMERICA THROMBECTOMY DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
TABLE 43 NORTH AMERICA NEUROVASCULAR INTERVENTION DEVICES MARKET REVENUE, BY APPLICATION, (2019-2027) ($MN)
TABLE 44 NORTH AMERICA NEUROVASCULAR INTERVENTION DEVICES MARKET REVENUE, BY COUNTRY, (2019-2027) ($MN)
TABLE 45 EUROPE NEUROVASCULAR INTERVENTION DEVICES MARKET REVENUE, BY PRODUCT, (2019-2027) ($MN)
TABLE 46 EUROPE ARTIFICIAL EMBOLIZATION DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
TABLE 47 EUROPE COILS MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
TABLE 48 EUROPE STENTS MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
TABLE 49 EUROPE INTRACRANIAL STENTS MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
TABLE 50 EUROPE THROMBECTOMY DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
TABLE 51 EUROPE NEUROVASCULAR INTERVENTION DEVICES MARKET REVENUE, BY APPLICATION, (2019-2027) ($MN)
TABLE 52 EUROPE NEUROVASCULAR INTERVENTION DEVICES MARKET REVENUE, BY COUNTRY, (2019-2027) ($MN)
TABLE 53 APAC NEUROVASCULAR INTERVENTION DEVICES MARKET REVENUE, BY PRODUCT, (2019-2027) ($MN)
TABLE 54 APAC ARTIFICIAL EMBOLIZATION DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
TABLE 55 APAC COILS MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
TABLE 56 APAC STENTS MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
TABLE 57 APAC INTRACRANIAL STENTS MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
TABLE 58 APAC THROMBECTOMY DEVICE MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
TABLE 59 APAC NEUROVASCULAR INTERVENTION DEVICES MARKET REVENUE, BY APPLICATION, (2019-2027) ($MN)
TABLE 60 APAC NEUROVASCULAR INTERVENTION DEVICES MARKET REVENUE, BY COUNTRY, (2019-2027) ($MN)
TABLE 61 ROW NEUROVASCULAR INTERVENTION DEVICES MARKET REVENUE, BY PRODUCT, (2019-2027) ($MN)
TABLE 62 ROW ARTIFICIAL EMBOLIZATION DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
TABLE 63 ROW COILS MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
TABLE 64 ROW STENTS MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
TABLE 65 ROW INTRACRANIAL STENTS MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
TABLE 66 ROW THROMBECTOMY DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
TABLE 67 ROW NEUROVASCULAR INTERVENTION DEVICES MARKET REVENUE, BY APPLICATION, (2019-2027) ($MN)
TABLE 68 ROW NEUROVASCULAR INTERVENTION DEVICES MARKET REVENUE, BY COUNTRY, (2019-2027) ($MN)
TABLE 69 KEY DEVELOPMENTS (2018 –2020)
TABLE 70 PRODUCT APPROVAL
TABLE 71 AGREEMENTS
TABLE 72 PRODUCT LAUNCH
TABLE 73 ACQUISITION
TABLE 74 OTHER DEVELOPMENTS
TABLE 75 ABBOTT LABORATORIES: TOTAL REVENUE AND R&D EXPENSES, (2018-2020) ($MN)
TABLE 76 ABBOTT LABORATORIES: TOTAL REVENUE BY SEGMENTS, (2018-2020) ($MN)
TABLE 77 ABBOTT LABORATORIES: MEDICAL DEVICES REVENUE BY SUB-SEGMENTS, (2018-2020) ($MN)
TABLE 78 ABBOTT LABORATORIES: TOTAL REVENUE BY GEOGRAPHY, (2018-2020) ($MN)
TABLE 79 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2018-2020) ($MN)
TABLE 80 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2018-2020) ($MN)
TABLE 81 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2018-2020) ($MN)
TABLE 82 JOHNSON & JOHNSON: TOTAL REVENUE AND R&D EXPENSES, (2018 -2020) ($MN)
TABLE 83 JOHNSON & JOHNSON: TOTAL REVENUE, BY SEGMENTS, (2018-2020) ($MN)
TABLE 84 JOHNSON & JOHNSON: MEDICAL DEVICE REVENUE, BY SUB-SEGMENTS, (2018-2020) ($MN)
TABLE 85 JOHNSON & JOHNSON: TOTAL REVENUE, BY GEOGRAPHY, (2018-2020) ($MN)
TABLE 86 MEDTRONIC PLC: TOTAL REVENUE AND OPERATING EXPENSES (2019-2021) ($MN)
TABLE 87 MEDTRONIC PLC: TOTAL REVENUE, BY SEGMENT, (2019-2021) ($MN)
TABLE 88 MEDTRONIC PLC: TOTAL REVENUE, BY GEOGRAPHY, (2019-2021) ($MN)
TABLE 89 MICROPORT SCIENTIFIC CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2018-2020) ($MN)
TABLE 90 MICROPORT SCIENTIFIC CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2018-2020) ($MN)
TABLE 91 MICROPORT SCIENTIFIC CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2017-2019) ($MN)
TABLE 92 PENUMBRA, INC: TOTAL REVENUE AND R&D EXPENSES, (2018-2020) ($MN)
TABLE 93 PENUMBRA, INC: TOTAL REVENUE, BY SEGMENTS, (2018-2020) ($MN)
TABLE 94 PENUMBRA, INC: TOTAL REVENUE, BY GEOGRAPHY, (2018-2020) ($MN)
TABLE 95 SILK ROAD MEDICAL INC: TOTAL REVENUE AND OPERATING EXPENSES (2018 -2020) ($MN)
TABLE 96 STRYKER CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2018-2020) ($MN)
TABLE 97 STRYKER CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2018-2020) ($MN)
TABLE 98 STRYKER CORPORATION: NEUROTECHNOLOGY AND SPINE REVENUE, BY SUB-SEGMENT, (2018-2020) ($MN)
TABLE 99 STRYKER CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2018-2020) ($MN)
TABLE 100 TERUMO CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2017-2019) ($MN)
TABLE 101 TERUMO CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2017-2019) ($MN)
TABLE 102 TERUMO CORPORATION: TOTAL REVENUE, BY GEOGRAPHY (2017-2019) ($MN)
LIST OF FIGURES
FIGURE 1 NEUROVASCULAR INTERVENTION DEVICES GLOBAL MARKET REVENUE, BY REGION (2019-2027) ($MN)
FIGURE 2 RESEARCH METHODOLOGY: NEUROVASCULAR INTERVENTION DEVICES GLOBAL MARKET
FIGURE 3 NEUROVASCULAR INTERVENTION DEVICES GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
FIGURE 4 NEUROVASCULAR INTERVENTION DEVICES GLOBAL MARKET: FORECASTING MODEL
FIGURE 5 NEUROVASCULAR INTERVENTION DEVICES GLOBAL MARKET: MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 6 NEUROVASCULAR INTERVENTION DEVICES GLOBAL MARKET SEGMENTATION
FIGURE 7 MARKET DYNAMICS
FIGURE 8 NEUROVASCULAR INTERVENTION DEVICES GLOBAL MARKET: PATENT FILING BY MAJOR PLAYERS (2015–2019)
FIGURE 9 NEUROVASCULAR INTERVENTION DEVICES GLOBAL MARKET: PORTER’S ANALYSIS
FIGURE 10 NEUROVASCULAR INTERVENTION DEVICES GLOBAL MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 11 NEUROVASCULAR INTERVENTION DEVICES GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2020 (%)
FIGURE 12 COILS GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2020 (%)
FIGURE 13 FLOW DIVERTERS GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2020 (%)
FIGURE 14 INTRACRANIAL STENT GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2020 (%)
FIGURE 15 CAROTID STENT GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2020 (%)
FIGURE 16 STENT RETRIEVER MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2020 (%)
FIGURE 17 ASPIRATION CATHETERS MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2020 (%)
FIGURE 18 LIQUID EMBOLICS MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2020 (%)
FIGURE 19 COIL NUMBER OF UNITS, BY REGION (2020 V/S 2027) (NO’S)
FIGURE 20 LIQUID EMBOLICS NUMBER OF UNITS, BY REGION (2020 V/S2027) (NO’S)
FIGURE 21 STENT RETREIVER NUMBER OF UNITS, BY REGION (2020 V/S 2027) (NO’S)
FIGURE 22 ASPIRATION DEVICES NUMBER OF UNITS, BY REGION (2020 V/S 2027) (NO’S)
FIGURE 23 INTRACRANIAL STENTS NUMBER OF UNITS, BY REGION (2020 V/S 2027) (NO’S)
FIGURE 24 CAROTID STENT NUMBER OF UNITS, BY REGION (2020 V/S 2027) (NO’S)
FIGURE 25 U.S. NEUROVASCULAR INTERVENTION DEVICES MARKET PENETRATION, BY APPLICATION (2020) (%)
FIGURE 26 NEUROVASCULAR INTERVENTION DEVICES GLOBAL MARKET SHARE, BY PRODUCT (2020 V/S 2027) (%)
FIGURE 27 ARTIFICIAL EMBOLIZATION DEVICES GLOBAL MARKET SHARE, BY PRODUCT TYPE (2020 V/S 2027) (%)
FIGURE 28 COILS GLOBAL MARKET SHARE, BY PRODUCT TYPE, (2020 V/S 2027) (%)
FIGURE 29 BARE METAL COILS GLOBAL MARKET SHARE, BY REGION, (2020 V/S 2027) (%)
FIGURE 30 FLOW DISRUPTOR GLOBAL MARKET SHARE, BY REGION, (2020 V/S 2027) (%)
FIGURE 31 STENTS GLOBAL MARKET SHARE, BY PRODUCT TYPE (2020 V/S 2027) (%)
FIGURE 32 INTRACRANIAL STENTS GLOBAL MARKET SHARE, BY PRODUCT TYPE, (2020 V/S 2027) (%)
FIGURE 33 INTRACRANIAL STENTS GLOBAL MARKET SHARE, BY REGION, (2020 V/S 2027) (%)
FIGURE 34 STENOSIS STENTS GLOBAL MARKET SHARE, BY REGION, (2020 V/S 2027) (%)
FIGURE 35 ANEURYSM COIL STENTS GLOBAL MARKET SHARE, BY REGION, (2020 V/S 2027) (%)
FIGURE 36 THROMBECTOMY DEVICES GLOBAL MARKET SHARE, BY TYPE (2020 V/S 2027) (%)
FIGURE 37 NEUROVASCULAR INTERVENTION DEVICES GLOBAL MARKET SHARE, BY APPLICATION, (2020 V/S 2027) (%)
FIGURE 38 NEUROVASCULAR INTERVENTION DEVICES GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN), CAGR (%)
FIGURE 39 NORTH AMERICA ARTFICIAL EMBOLIZATION DEVICES MARKET SHARE, BY PRODUCT TYPE, (2020 VS 2027) (%)
FIGURE 40 NORTH AMERICA COILS MARKET SHARE, BY PRODUCT TYPE, (2020 VS 2027) (%)
FIGURE 41 NORTH AMERICA STENTS MARKET SHARE, BY PRODUCT TYPE, (2020 VS 2027) (%)
FIGURE 42 NORTH AMERICA INTRACRANIAL STENTS MARKET SHARE, BY PRODUCT TYPE, (2020 VS 2027) (%)
FIGURE 43 NORTH AMERICA THROMBECTOMY DEVICES MARKET SHARE, BY PRODUCT TYPE, (2020 V/S 2027) (%)
FIGURE 44 NORTH AMERICA NEUROVASCULAR INTERVENTION DEVICES MARKET SHARE, BY PRODUCT & APPLICATION, (2020 V/S 2027) (%)
FIGURE 45 NORTH AMERICA NEUROVASCULAR INTERVENTION DEVICES MARKET SHARE, BY COUNTRY, (2020 V/S 2027) (%)
FIGURE 46 U.S. NEUROVASCULAR INTERVENTION DEVICES MARKET REVENUE, BY PRODUCT & APPLICATION, (2020 VS 2027) ($MN)
FIGURE 47 REST OF NORTH AMERICA NEUROVASCULAR INTERVENTION DEVICES MARKET REVENUE, BY PRODUCT & APPLICATION, (2020 V/S 2027) ($MN)
FIGURE 48 EUROPE ARTIFICIAL EMBOLIZATION DEVICES MARKET SHARE, BY PRODUCT TYPE (2020 VS 2027) (%)
FIGURE 49 EUROPE COILS MARKET SHARE, BY PRODUCT TYPE (2020 V/S 2027) (%)
FIGURE 50 EUROPE STENTS MARKET SHARE, BY PRODUCT TYPE, (2020 V/S 2027) (%)
FIGURE 51 EUROPE INTRACRANIAL STENTS MARKET SHARE, BY PRODUCT TYPE (2020 V/S 2027) (%)
FIGURE 52 EUROPE THROMBECTOMY DEVICES MARKET SHARE, BY PRODUCT TYPE, (2020 V/S 2027) (%)
FIGURE 53 EUROPE NEUROVASCULAR INTERVENTION DEVICES MARKET SHARE, BY PRODUCT & APPLICATION, (2020 VS 2027) (%)
FIGURE 54 EUROPE NEUROVASCULAR INTERVENTION DEVICES MARKET SHARE, BY COUNTRY, (2020 V/S 2027) (%)
FIGURE 55 GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET REVENUE, BY PRODUCT & APPLICATION, (2020 V/S 2027) ($MN)
FIGURE 56 U.K. NEUROVASCULAR INTERVENTION DEVICES MARKET REVENUE, BY PRODUCT & APPLICATION, (2020 V/S 2027) ($MN)
FIGURE 57 FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET REVENUE, BY PRODUCT & APPLICATION, (2020 V/S 2027) ($MN)
FIGURE 58 REST OF EUROPE NEUROVASCULAR INTERVENTION DEVICES MARKET REVENUE, BY PRODUCT & APPLICATION, (2020 VS 2027) ($MN)
FIGURE 59 APAC ARTIFICIAL EMBOLIZATION MARKET SHARE, BY PRODUCT TYPE, (2020 V/S 2027) (%)
FIGURE 60 APAC COILS MARKET SHARE, BY PRODUCT TYPE, (2020 V/S 2027) (%)
FIGURE 61 APAC STENTS MARKET SHARE, BY PRODUCT TYPE, (2020 V/S 2027) (%)
FIGURE 62 APAC INTRACRANIAL STENTS MARKET SHARE, BY PRODUCT TYPE, (2020 V/S 2027) (%)
FIGURE 63 APAC THROMBECTOMY DEVICES MARKET SHARE, BY PRODUCT TYPE, (2020 V/S 2027) (%)
FIGURE 64 APAC NEUROVASCULAR INTERVENTION DEVICES MARKET SHARE, BY PRODUCT & APPLICATION, (2020 V/S 2027) (%)
FIGURE 65 APAC NEUROVASCULAR INTERVENTION DEVICES MARKET SHARE, BY COUNTRY, (2020 V/S 2027) (%)
FIGURE 66 JAPAN NEUROVASCULAR INTERVENTION DEVICES MARKET REVENUE, BY PRODUCT & APPLICATION, (2020 V/S 2027) ($MN)
FIGURE 67 CHINA NEUROVASCULAR INTERVENTION DEVICES MARKET REVENUE, BY PRODUCT & APPLICATION, (2020 V/S 2027) ($MN)
FIGURE 68 INDIA NEUROVASCULAR INTERVENTION DEVICES MARKET REVENUE, BY PRODUCT & APPLICATION, (2020 V/S 2027) ($MN)
FIGURE 69 REST OF APAC COUNTRIES NEUROVASCULAR INTERVENTION DEVICES MARKET REVENUE, BY PRODUCT & APPLICATION (2020 V/S 2027) ($MN)
FIGURE 70 ROW ARTIFICIAL EMBOLIZATION DEVICES MARKET SHARE, BY PRODUCT TYPE, (2020 V/S 2027) (%)
FIGURE 71 ROW COILS MARKET SHARE, BY PRODUCT TYPE, (2020 V/S 2027) (%)
FIGURE 72 ROW STENTS MARKET SHARE, BY PRODUCT TYPE, (2020 V/S 2027) (%)
FIGURE 73 ROW INTRACRANIAL STENTS MARKET SHARE, BY PRODUCT TYPE, (2020 V/S 2027) (%)
FIGURE 74 ROW THROMBECTOMY DEVICES MARKET SHARE, BY PRODUCT TYPE, (2020 V/S 2027) (%)
FIGURE 75 ROW NEUROVASCULAR INTERVENTION DEVICES MARKET SHARE, BY PRODUCT & APPLICATION, (2020 V/S 2027) (%)
FIGURE 76 ROW NEUROVASCULAR INTERVENTION DEVICES MARKET SHARE, BY COUNTRY, (2020 V/S 2027) (%)
FIGURE 77 BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET REVENUE, BY PRODUCT & APPLICATION, (2020 V/S 2027) ($MN)
FIGURE 78 REST OF LATIN AMERICA NEUROVASCULAR INTERVENTION DEVICES MARKET REVENUE, BY PRODUCT & APPLICATION, (2020 V/S 2027) ($MN)
FIGURE 79 MIDDLE EAST AND OTHERS NEUROVASCULAR INTERVENTION DEVICES MARKET REVENUE, BY PRODUCT & APPLICATION, (2020 V/S 2027) ($MN)
FIGURE 80 SWOT: ABBOTT LABORATORIES
FIGURE 81 SWOT: BALT EXTRUSION
FIGURE 82 SWOT: BOSTON SCIENTIFIC CORPORATION
FIGURE 83 SWOT: JOHNSON & JOHNSON
FIGURE 84 SWOT: MEDTRONIC PLC
FIGURE 85 SWOT: MICROPORT SCIENTIFIC CORPORATION
FIGURE 86 SWOT: PENUMBRA, INC
FIGURE 87 SWOT: SILK ROAD MEDICAL, INC
FIGURE 88 SWOT: STRYKER CORPORATION
FIGURE 89 SWOT: TERUMO CORPORATION
FIGURE 1 NEUROVASCULAR INTERVENTION DEVICES GLOBAL MARKET REVENUE, BY REGION (2019-2027) ($MN)
FIGURE 2 RESEARCH METHODOLOGY: NEUROVASCULAR INTERVENTION DEVICES GLOBAL MARKET
FIGURE 3 NEUROVASCULAR INTERVENTION DEVICES GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
FIGURE 4 NEUROVASCULAR INTERVENTION DEVICES GLOBAL MARKET: FORECASTING MODEL
FIGURE 5 NEUROVASCULAR INTERVENTION DEVICES GLOBAL MARKET: MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 6 NEUROVASCULAR INTERVENTION DEVICES GLOBAL MARKET SEGMENTATION
FIGURE 7 MARKET DYNAMICS
FIGURE 8 NEUROVASCULAR INTERVENTION DEVICES GLOBAL MARKET: PATENT FILING BY MAJOR PLAYERS (2015–2019)
FIGURE 9 NEUROVASCULAR INTERVENTION DEVICES GLOBAL MARKET: PORTER’S ANALYSIS
FIGURE 10 NEUROVASCULAR INTERVENTION DEVICES GLOBAL MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 11 NEUROVASCULAR INTERVENTION DEVICES GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2020 (%)
FIGURE 12 COILS GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2020 (%)
FIGURE 13 FLOW DIVERTERS GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2020 (%)
FIGURE 14 INTRACRANIAL STENT GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2020 (%)
FIGURE 15 CAROTID STENT GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2020 (%)
FIGURE 16 STENT RETRIEVER MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2020 (%)
FIGURE 17 ASPIRATION CATHETERS MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2020 (%)
FIGURE 18 LIQUID EMBOLICS MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2020 (%)
FIGURE 19 COIL NUMBER OF UNITS, BY REGION (2020 V/S 2027) (NO’S)
FIGURE 20 LIQUID EMBOLICS NUMBER OF UNITS, BY REGION (2020 V/S2027) (NO’S)
FIGURE 21 STENT RETREIVER NUMBER OF UNITS, BY REGION (2020 V/S 2027) (NO’S)
FIGURE 22 ASPIRATION DEVICES NUMBER OF UNITS, BY REGION (2020 V/S 2027) (NO’S)
FIGURE 23 INTRACRANIAL STENTS NUMBER OF UNITS, BY REGION (2020 V/S 2027) (NO’S)
FIGURE 24 CAROTID STENT NUMBER OF UNITS, BY REGION (2020 V/S 2027) (NO’S)
FIGURE 25 U.S. NEUROVASCULAR INTERVENTION DEVICES MARKET PENETRATION, BY APPLICATION (2020) (%)
FIGURE 26 NEUROVASCULAR INTERVENTION DEVICES GLOBAL MARKET SHARE, BY PRODUCT (2020 V/S 2027) (%)
FIGURE 27 ARTIFICIAL EMBOLIZATION DEVICES GLOBAL MARKET SHARE, BY PRODUCT TYPE (2020 V/S 2027) (%)
FIGURE 28 COILS GLOBAL MARKET SHARE, BY PRODUCT TYPE, (2020 V/S 2027) (%)
FIGURE 29 BARE METAL COILS GLOBAL MARKET SHARE, BY REGION, (2020 V/S 2027) (%)
FIGURE 30 FLOW DISRUPTOR GLOBAL MARKET SHARE, BY REGION, (2020 V/S 2027) (%)
FIGURE 31 STENTS GLOBAL MARKET SHARE, BY PRODUCT TYPE (2020 V/S 2027) (%)
FIGURE 32 INTRACRANIAL STENTS GLOBAL MARKET SHARE, BY PRODUCT TYPE, (2020 V/S 2027) (%)
FIGURE 33 INTRACRANIAL STENTS GLOBAL MARKET SHARE, BY REGION, (2020 V/S 2027) (%)
FIGURE 34 STENOSIS STENTS GLOBAL MARKET SHARE, BY REGION, (2020 V/S 2027) (%)
FIGURE 35 ANEURYSM COIL STENTS GLOBAL MARKET SHARE, BY REGION, (2020 V/S 2027) (%)
FIGURE 36 THROMBECTOMY DEVICES GLOBAL MARKET SHARE, BY TYPE (2020 V/S 2027) (%)
FIGURE 37 NEUROVASCULAR INTERVENTION DEVICES GLOBAL MARKET SHARE, BY APPLICATION, (2020 V/S 2027) (%)
FIGURE 38 NEUROVASCULAR INTERVENTION DEVICES GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN), CAGR (%)
FIGURE 39 NORTH AMERICA ARTFICIAL EMBOLIZATION DEVICES MARKET SHARE, BY PRODUCT TYPE, (2020 VS 2027) (%)
FIGURE 40 NORTH AMERICA COILS MARKET SHARE, BY PRODUCT TYPE, (2020 VS 2027) (%)
FIGURE 41 NORTH AMERICA STENTS MARKET SHARE, BY PRODUCT TYPE, (2020 VS 2027) (%)
FIGURE 42 NORTH AMERICA INTRACRANIAL STENTS MARKET SHARE, BY PRODUCT TYPE, (2020 VS 2027) (%)
FIGURE 43 NORTH AMERICA THROMBECTOMY DEVICES MARKET SHARE, BY PRODUCT TYPE, (2020 V/S 2027) (%)
FIGURE 44 NORTH AMERICA NEUROVASCULAR INTERVENTION DEVICES MARKET SHARE, BY PRODUCT & APPLICATION, (2020 V/S 2027) (%)
FIGURE 45 NORTH AMERICA NEUROVASCULAR INTERVENTION DEVICES MARKET SHARE, BY COUNTRY, (2020 V/S 2027) (%)
FIGURE 46 U.S. NEUROVASCULAR INTERVENTION DEVICES MARKET REVENUE, BY PRODUCT & APPLICATION, (2020 VS 2027) ($MN)
FIGURE 47 REST OF NORTH AMERICA NEUROVASCULAR INTERVENTION DEVICES MARKET REVENUE, BY PRODUCT & APPLICATION, (2020 V/S 2027) ($MN)
FIGURE 48 EUROPE ARTIFICIAL EMBOLIZATION DEVICES MARKET SHARE, BY PRODUCT TYPE (2020 VS 2027) (%)
FIGURE 49 EUROPE COILS MARKET SHARE, BY PRODUCT TYPE (2020 V/S 2027) (%)
FIGURE 50 EUROPE STENTS MARKET SHARE, BY PRODUCT TYPE, (2020 V/S 2027) (%)
FIGURE 51 EUROPE INTRACRANIAL STENTS MARKET SHARE, BY PRODUCT TYPE (2020 V/S 2027) (%)
FIGURE 52 EUROPE THROMBECTOMY DEVICES MARKET SHARE, BY PRODUCT TYPE, (2020 V/S 2027) (%)
FIGURE 53 EUROPE NEUROVASCULAR INTERVENTION DEVICES MARKET SHARE, BY PRODUCT & APPLICATION, (2020 VS 2027) (%)
FIGURE 54 EUROPE NEUROVASCULAR INTERVENTION DEVICES MARKET SHARE, BY COUNTRY, (2020 V/S 2027) (%)
FIGURE 55 GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET REVENUE, BY PRODUCT & APPLICATION, (2020 V/S 2027) ($MN)
FIGURE 56 U.K. NEUROVASCULAR INTERVENTION DEVICES MARKET REVENUE, BY PRODUCT & APPLICATION, (2020 V/S 2027) ($MN)
FIGURE 57 FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET REVENUE, BY PRODUCT & APPLICATION, (2020 V/S 2027) ($MN)
FIGURE 58 REST OF EUROPE NEUROVASCULAR INTERVENTION DEVICES MARKET REVENUE, BY PRODUCT & APPLICATION, (2020 VS 2027) ($MN)
FIGURE 59 APAC ARTIFICIAL EMBOLIZATION MARKET SHARE, BY PRODUCT TYPE, (2020 V/S 2027) (%)
FIGURE 60 APAC COILS MARKET SHARE, BY PRODUCT TYPE, (2020 V/S 2027) (%)
FIGURE 61 APAC STENTS MARKET SHARE, BY PRODUCT TYPE, (2020 V/S 2027) (%)
FIGURE 62 APAC INTRACRANIAL STENTS MARKET SHARE, BY PRODUCT TYPE, (2020 V/S 2027) (%)
FIGURE 63 APAC THROMBECTOMY DEVICES MARKET SHARE, BY PRODUCT TYPE, (2020 V/S 2027) (%)
FIGURE 64 APAC NEUROVASCULAR INTERVENTION DEVICES MARKET SHARE, BY PRODUCT & APPLICATION, (2020 V/S 2027) (%)
FIGURE 65 APAC NEUROVASCULAR INTERVENTION DEVICES MARKET SHARE, BY COUNTRY, (2020 V/S 2027) (%)
FIGURE 66 JAPAN NEUROVASCULAR INTERVENTION DEVICES MARKET REVENUE, BY PRODUCT & APPLICATION, (2020 V/S 2027) ($MN)
FIGURE 67 CHINA NEUROVASCULAR INTERVENTION DEVICES MARKET REVENUE, BY PRODUCT & APPLICATION, (2020 V/S 2027) ($MN)
FIGURE 68 INDIA NEUROVASCULAR INTERVENTION DEVICES MARKET REVENUE, BY PRODUCT & APPLICATION, (2020 V/S 2027) ($MN)
FIGURE 69 REST OF APAC COUNTRIES NEUROVASCULAR INTERVENTION DEVICES MARKET REVENUE, BY PRODUCT & APPLICATION (2020 V/S 2027) ($MN)
FIGURE 70 ROW ARTIFICIAL EMBOLIZATION DEVICES MARKET SHARE, BY PRODUCT TYPE, (2020 V/S 2027) (%)
FIGURE 71 ROW COILS MARKET SHARE, BY PRODUCT TYPE, (2020 V/S 2027) (%)
FIGURE 72 ROW STENTS MARKET SHARE, BY PRODUCT TYPE, (2020 V/S 2027) (%)
FIGURE 73 ROW INTRACRANIAL STENTS MARKET SHARE, BY PRODUCT TYPE, (2020 V/S 2027) (%)
FIGURE 74 ROW THROMBECTOMY DEVICES MARKET SHARE, BY PRODUCT TYPE, (2020 V/S 2027) (%)
FIGURE 75 ROW NEUROVASCULAR INTERVENTION DEVICES MARKET SHARE, BY PRODUCT & APPLICATION, (2020 V/S 2027) (%)
FIGURE 76 ROW NEUROVASCULAR INTERVENTION DEVICES MARKET SHARE, BY COUNTRY, (2020 V/S 2027) (%)
FIGURE 77 BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET REVENUE, BY PRODUCT & APPLICATION, (2020 V/S 2027) ($MN)
FIGURE 78 REST OF LATIN AMERICA NEUROVASCULAR INTERVENTION DEVICES MARKET REVENUE, BY PRODUCT & APPLICATION, (2020 V/S 2027) ($MN)
FIGURE 79 MIDDLE EAST AND OTHERS NEUROVASCULAR INTERVENTION DEVICES MARKET REVENUE, BY PRODUCT & APPLICATION, (2020 V/S 2027) ($MN)
FIGURE 80 SWOT: ABBOTT LABORATORIES
FIGURE 81 SWOT: BALT EXTRUSION
FIGURE 82 SWOT: BOSTON SCIENTIFIC CORPORATION
FIGURE 83 SWOT: JOHNSON & JOHNSON
FIGURE 84 SWOT: MEDTRONIC PLC
FIGURE 85 SWOT: MICROPORT SCIENTIFIC CORPORATION
FIGURE 86 SWOT: PENUMBRA, INC
FIGURE 87 SWOT: SILK ROAD MEDICAL, INC
FIGURE 88 SWOT: STRYKER CORPORATION
FIGURE 89 SWOT: TERUMO CORPORATION
